Project Details
Description
A Phase IB/II study of nivolumab in combination with ALT-803 in patients with pretreated, advanced or metastatic non-small cell lung cance
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/16 → 10/31/23 |
Funding
- MEDICAL UNIVERSITY OF SOUTH CAROLINA
- ALTOR BIOSCIENCE LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.